Retinal pericytes and cytomegalovirus infectivity: implications for HCMV-induced retinopathy and congenital ocular disease

Journal of Neuroinflammation

Donald J Alcendor¹  Nader Sheibani²  Johnathan M Mitchell¹  Joshua Laban¹  Irene Wilkerson¹ 

[1] Department of Microbiology and Immunology, Center for AIDS Health Disparities Research, Meharry Medical College, School of Medicine, 1005 Dr DB Todd Jr Blvd, Nashville 37208, TN, USA;Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison 53792, WI, USA

关键词: Angiogenesis;    Inflammation;    Cytokines;    Blood-brain barrier;    Retina;    Pericytes;    Cytomegalovirus;   

Others  :  1133404
DOI  :  10.1186/s12974-014-0219-y

 received in 2014-10-13, accepted in 2014-12-09,  发布年份 2015

【 摘 要 】

Background

Human cytomegalovirus (HCMV) is the leading infectious cause of vision loss among congenitally infected children. Retinal pericytes play an essential role in maintaining retinal vascular and endothelial cell proliferation. However, the role of retinal pericytes in ocular HCMV pathogenesis is unknown.

Methods

Retinal pericytes were exposed to clinical (SBCMV) and lab strains of HCMV; infectivity was analyzed by microscopy, immunofluorescence and qRT-PCR (reverse transcription polymerase chain reaction). Cytokine expression was examined by Luminex assay. Recombinant HCMV-GPF was used to examine viral replication kinetics. A Tricell culture model of the inner blood-retinal barrier (IBRB) was examined for cell type infectivity using immunohistochemistry.

Results

Retinal pericytes expressed the biomarker neuron-glial antigen 2. Antigenic expression profiles for several cytoskeletal, cell adhesion and inflammatory proteins were shared by both retinal and brain pericytes. Infected pericytes showed cytomegalic cytopathology and expressed mRNAs for the major immediate protein (MIE) and HCMV phosphorylated envelop protein 65. qRT-PCR analysis showed full lytic replication of HCMV in retinal pericytes. Pericytes exposed to SBCMV for 9 days expressed higher levels of vascular endothelial cell growth factor mRNA compared to controls. Luminex analysis of supernatants from SBCMV-infected retinal pericytes had increased levels of macrophage inflammatory protein-1α, beta-2 microglobulin (B2-m), matrix metalloproteinase-3 and -9 (MMP3/9), and lower levels of IL-6 and IL-8 compared to controls. At 24 hours post infection, pericytes expressed higher levels of IL-8, TIMP-1 (tissue inhibitor of metalloproteinase-1), and RANTES (regulated upon activation normal T cell-expressed and presumably secreted) but lower levels of MMP9. Time course analysis showed that both brain and retinal pericytes were more permissive for HCMV infection than other cellular components of the BBB (blood-brain barrier) and IBRB. Using a Tricell culture model of the IBRB (retinal endothelial, pericytes, Müller cells), retinal pericytes were most permissive for SBCMV infection. SBCMV infection of this IBRB Tricell mixture for 96 hours resulted in increased levels of IL-6, MMP9, and stem cell factor with a concomitant decrease in granulocyte-macrophage colony-stimulating factor and TNF-alpha.

Conclusion

In retinal pericytes, HCMV induces proinflammatory and angiogenic cytokines. In the IBRB, pericytes likely serve as an amplification reservoir which contributes to retinal inflammation and angiogenesis.

【 授权许可】

   
2015 Wilkerson et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

Figure 10.

Figure 11.

【 参考文献 】

• [1]Razonable RR, Paya CV: Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes 2003, 10:60-5.
• [2]Boppana SB, Ross SA, Fowler KB: Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis 2013, Suppl 4:S178-81.
• [3]Colugnati FA, Staras SA, Dollard SC, Cannon MJ: Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis 2007, 7:71. BioMed Central Full Text
• [4]Sessions CF, Taeusch HW: Viral infections of the newborn. In Diseases of the Newborn. Edited by Taeusch HW, Ballard RA, Avery ME. W. B. Saunders, Philadelphia; 1991:331-49.
• [5]Stagno S, Pass RF, Dworsky ME, Henderson RE, Moore EG, Walton PD, et al.: Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection. N Engl J Med 1982, 306:945-9.
• [6]Demmler GJ: Congenital cytomegalovirus infection and disease. Adv Pediatr Infect Dis 1996, 11:135-62.
• [7]Stagno S, Reynolds DW, Amos CS, Dahle AJ, McCollister FP, Mohindra I, et al.: Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegaloviral and toxoplasma infections. Pediatrics 1977, 59:669-78.
• [8]Fowler K, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF: Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997, 130:624-30.
• [9]Boppana SB, Fowler KB, Pass RF, Rivera LB, Bradford RD, Lakeman FD, et al.: Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 2005, 146:817-23.
• [10]Kong L, Fry M, Al-Samarraie M, Gilbert C, Steinkuller PG: An update on progress and the changing epidemiology of causes of childhood blindness worldwide. J AAPOS 2012, 16:501-7.
• [11]Boppana SB, Fowler KB, Vaid Y, Hedlund G, Stagno S, Britt WJ, et al.: Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 1997, 99:409-14.
• [12]Cheeran MCJ, Lokensgard JR, Schleiss MR: Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev 2009, 22:99-126.
• [13]Butler NJ, Thorne JE: Current status of HIV infection and ocular disease. Curr Opin Opthalmol 2012, 23:517-22.
• [14]Culbertson WW: Infections of the retina in AIDS. Int Ophthalmol Clin 1989, 29:108-18.
• [15]Jacobson MA, Mills J: Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988, 108:585-94.
• [16]Jabs DA: Acquired immunodeficiency syndrome and the eye. Arch Ophthalmol 1996, 114:863-6.
• [17]Iyer JV, Connolly J, Agrawal R, Yeo TK, Lee B, Au B, et al.: Analysis of aqueous humor in HIV patients with cytomegalovirus retinitis. Cytokine 2013, 2:541-7.
• [18]Smith IL, Macdonald JC, Freeman WR, Shapiro AM, Spector SA: Cytomegalovirus (CMV) retinitis activity is accurately reflected by the presence and level of CMV DNA in aqueous humor and vitreous. J Infect Dis 1999, 5:1249-53.
• [19]Sims DE: The pericyte - a review. Tissue Cell 1986, 18:153-74.
• [20]Alcendor DJ, Charest AM, Zhu WQ, Vigil HE, Knobel SM: Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirus. J Neuroinflammation 2012, 9:95. BioMed Central Full Text
• [21]Hosoya K, Tachikawa M: The inner blood-retinal barrier: molecular structure and transport biology. Adv Exp Med Biol 2012, 763:85-104.
• [22]Alcendor DJ, Block FE 3rd, Cliffel DE, Daniels JS, Ellacott KL, Goodwin CR, et al.: Neurovascular unit on a chip: implications for translational applications. Stem Cell Res Ther 2013, 4(Suppl 1):S18. BioMed Central Full Text
• [23]Hammes HP, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C, et al.: Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 2002, 51:3107-12.
• [24]Limb GA, Salt TE, Munro PM, Moss SE, Khaw PT: In vitro characterization of a spontaneously immortalized human Müller cell line (MIO-M1). Invest Ophthalmol Vis Sci 2002, 43:864-9.
• [25]Bryant P, Morley C, Garland S, Curtis N: Cytomegalovirus transmission from breast milk in premature babies: does it matter? Arch Dis Child Fetal Neonatal Ed 2002, 87:F75-7.
• [26]Djoba Siawaya JF, Roberts T, Babb C, Black G, Golakai HJ, Stanley K, et al.: An evaluation of commercial fluorescent bead-based luminex cytokine assays. PLoS One 2008, 7:e2535.
• [27]Alcendor DJ, Knobel S: Identifying dysregulated genes induced by Kaposi’s sarcoma-associated herpesvirus (KSHV). J Vis Exp 2010, 14:43.
• [28]Barnett JM, McCollum GW, Penn JS: Role of cytosolic phospholipase A2 in retinal neovascularization. Invest Ophthalmol Vis Sci 2010, 2:1136-42.
• [29]Colberg-Poley AM: Functional roles of immediate early proteins encoded by the human cytomegalovirus UL36-38, UL115-119, TRS1/IRS1 and US3 loci. Intervirology 1996, 39:350-60.
• [30]Reyda S, Tenzer S, Navarro P, Gebauer W, Saur M, Krauter S, et al.: The tegument protein pp 65 of human cytomegalovirus acts as an optional scaffold protein that optimizes protein uploading into viral particles. J Virol 2014, 88:9633-46.
• [31]Gariano RF, Gardner TW: Retinal angiogenesis in development and disease. Nature 2005, 7070:960-6.
• [32]Banumathi E, O'Connor A, Gurunathan S, Simpson DA, McGeown JG, Curtis TM: VEGF-induced retinal angiogenic signaling is critically dependent on Ca2+ signaling by Ca2+/calmodulin-dependent protein kinase II. Invest Ophthalmol Vis Sci 2011, 6:3103-11.
• [33]Hamdollah Zadeh MA, Glass CA, Magnussen A, Hancox JC, Bates DO: VEGF-mediated elevated intracellular calcium and angiogenesis in human microvascular endothelial cells in vitro are inhibited by dominant negative TRPC6. Microcirculation 2008, 7:605-14.
• [34]Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, et al.: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994, 118:445-50.
• [35]Nordøy I, Müller F, Nordal KP, Rollag H, Aukrust P, Frøland SS: Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection. Clin Exp Immunol 2000, 2:333-7.
• [36]Salazar-Mather TP, Hamilton TA, Biron CA: A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest 2000, 7:985-93.
• [37]Botero JE, Contreras A, Parra B: Profiling of inflammatory cytokines produced by gingival fibroblasts after human cytomegalovirus infection. Oral Microbiol Immunol 2008, 4:291-8.
• [38]Salazar Mather TP, Hokeness KL: Calling in the troops: regulation of inflammatory cell trafficking through innate cytokine/chemokine networks. Viral Immunol 2003, 3:291-306.
• [39]Dreux S, Rousseau T, Gerber S, Col JY, Dommergues M, Muller F: Fetal serum beta2-microglobulin as a marker for fetal infectious diseases. Prenat Diagn 2006, 5:471-4.
• [40]Alarcon A, Martinez-Biarge M, Cabañas F, Hernanz A, Quero J, Garcia-Alix A: Clinical, biochemical, and neuroimaging findings predict long-term neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Pediatr 2013, 3:828-34.
• [41]Fabbri E, Revello MG, Furione M, Zavattoni M, Lilleri D, Tassis B, et al.: Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood. BJOG 2011, 4:448-56.
• [42]Prochnau D, Lehmann M, Straube E, Figulla HR, Rödel J: Human cytomegalovirus induces MMP-1 and MMP-3 expression in aortic smooth muscle cells. Acta Microbiol Immunol Hung 2011, 4:303-17.
• [43]Acera A, Vecino E, Duran JA: Tear MMP-9 levels as a marker of ocular surface inflammation in conjunctivochalasis. Invest Ophthalmol Vis Sci 2013, 13:8285-91.
• [44]Kaufman HE: The practical detection of mmp-9 diagnoses ocular surface disease and may help prevent its complications. Cornea 2013, 2:211-6.
• [45]Gealy C, Denson M, Humphreys C, McSharry B, Wilkinson G, Caswell R: Posttranscriptional suppression of interleukin-6 production by human cytomegalovirus. J Virol 2005, 79:472-85.
• [46]Strååt K, de Klark R, Gredmark-Russ S, Eriksson P, Söderberg-Nauclér C: Infection with human cytomegalovirus alters the MMP-9/TIMP-1 balance in human macrophages. J Virol 2009, 2:830-5.
• [47]Nachtwey J, Spencer JV: HCMV IL-10 suppresses cytokine expression in monocytes through inhibition of nuclear factor-kappaB. Viral Immunol 2008, 4:477-82.
• [48]Matlaf LA, Harkins LE, Bezrookove V, Cobbs CS, Soroceanu L: Cytomegalovirus pp 71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor. PLoS One 2013, 7:e68176.
• [49]Carlier J, Martin H, Mariamé B, Rauwel B, Mengelle C, Weclawiak H, et al.: Blood: Paracrine inhibition of GM-CSF signaling by human cytomegalovirus in monocytes differentiating to dendritic cells. Blood 2011, 26:6783-92.
• [50]Miller DM, Espinosa-Heidmann DG, Legra J, Dubovy SR, Sũner IJ, Sedmak DD, et al.: The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. Am J Ophthalmol 2004, 3:323-8.